Drug
Mitiglinide clinical trials
Also written Glufast and KAD-1229.
- studies test it
- 12
- open now
- 0
- in phase 3
- 4
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Brand
Development codes
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 3
- 4
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 3
Kissei Pharmaceutical Co., Ltd. (3) · JW Pharmaceutical (2) · AstraZeneca (1) · Orient Europharma Co., Ltd. (1) · Zhongda Hospital (1) · Astellas Pharma Inc (1) · Samsung Medical Center (1) · Seoul National University Hospital (1)
Often tested with
Tested in the same studies.
Elecoglipron (1) · Pioglitazone (1) · Ipragliflozin (1) · Metformin (1) · Sitagliptin (1)
Studies
Open first, then newest update. How each study uses mitiglinide is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy ParticipantsCompletedPhase 1AstraZenecaNCT07444424Written as Mitiglinide
- Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)CompletedPhase 4Orient Europharma Co., Ltd.NCT04349696Written as Mitiglinide
- Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes MellitusCompletedPhase 4Kissei Pharmaceutical Co., Ltd.NCT02154347Written as KAD-1229
- Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes MellitusCompletedPhase 4Zhongda HospitalNCT02143765Written as Mitiglinide
- Long-term Study of KAD-1229 in Type 2 Diabetes PatientsCompletedPhase 3Kissei Pharmaceutical Co., Ltd.NCT01333592Written as KAD-1229
- Glufast On Insulin Glargine Trial in Type 2 DMCompletedPhase 4JW PharmaceuticalNCT00663884Written as Mitiglinide
- A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma ConcentrationCompletedPhase 1Astellas Pharma IncNCT01403818Written as Mitiglinide calcium hydrate
- Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.CompletedPhase 1JW PharmaceuticalNCT01443221Written as mitiglinide and metformin
- Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and SitagliptinCompletedPhase 1Samsung Medical CenterNCT01422590Written as Mitiglinide
- Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes MellitusCompletedPhase 3Seoul National University HospitalNCT01037842Written as Mitiglinide
- Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes MellitusCompletedPhase 3Elixir PharmaceuticalsNCT00519142Written as mitiglinide
- Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic PatientsCompletedPhase 3Kissei Pharmaceutical Co., Ltd.NCT00461617Written as Mitiglinide
Codes
What other systems call mitiglinide · ClinicalTrials.gg INT003789
- MeSH (NLM) C087255mitiglinideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) D86I0XLB13MITIGLINIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q266321mitiglinideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81699MitiglinideOne source FDA
- DrugBank DB01252One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C087255 | mitiglinide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | D86I0XLB13 | MITIGLINIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q266321 | mitiglinide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81699 | Mitiglinide | One source FDA |
| DrugBank | DB01252 | — | One source Wikidata |
Also registered as mitiglinide calcium dihydrate (UNII 9651C21W3Z).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.